Hospira Australia Pty Limited T/A Pfizer Melbourne

Case •

[2023] FWCA 378

•

8 FEBRUARY 2023
[2023] FWCA 378

FAIR WORK COMMISSION

DECISION

Fair Work Act 2009

s.185—Enterprise agreement

Hospira Australia Pty Limited T/A Pfizer Melbourne

(AG2023/36)

PFIZER MELBOURNE & UWU ENTERPRISE AGREEMENT 2022

Pharmaceutical industry

DEPUTY PRESIDENT BOYCE

SYDNEY, 8 FEBRUARY 2023

Application for approval of the Pfizer Melbourne & UWU Enterprise Agreement 2022

  1. An application has been made for approval of an enterprise agreement to be known as the Pfizer Melbourne & UWU Enterprise Agreement 2022 (Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (Act). It has been made by Hospira Australia Pty Limited T/A Pfizer Melbourne (Employer). The Agreement is a single enterprise agreement.

Undertakings

  1. The Employer has provided written undertakings dated 6 February 2023. Those undertakings are attached at Annexure A to this decision and become terms of the Agreement. I am satisfied that the undertakings will not cause financial detriment to any employee covered by the Agreement (as compared to the relevant provisions of the Pharmaceutical Industry Award 2020), and that the undertakings will not result in substantial changes to the Agreement.

Coverage of employee organisation(s)

  1. The United Workers Union, being a bargaining representative for the Agreement, has given notice under s.183 of the Act that it wants to be covered by the Agreement. In accordance with s.201(2) of the Act, I note that the Agreement covers this organisation.

Conclusion

  1. Subject to the undertakings referred to above, I am satisfied that each of the requirements of ss.186, 187, 188 and 190 of the Act, as are relevant to this application for approval, have been met.

  1. I am satisfied the more beneficial entitlements of the NES will prevail where there is an inconsistency between the Agreement and the NES.

  1. The Agreement is approved and, in accordance with s.54 of the Act, will operate from 15 February 2023. The nominal expiry date of the Agreement is 1 March 2025.


DEPUTY PRESIDENT

Printed by authority of the Commonwealth Government Printer

<AE519104  PR750300>

Annexure A

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0